Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONTROL BIONICS LIMITED Board/Management Information 2022

Sep 14, 2022

64611_rns_2022-09-14_468debeb-cc22-4dbb-a50e-55e059c0d796.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [177 x 63] intentionally omitted <==

15 September 2022

ASX ANNOUNCEMENT

CEO Resignation

It is with deep regret that we announce the resignation of our CEO, Rob Wong, due to an ongoing, degenerative medical condition.

Rob has been on sick leave for the last 2 months seeking treatment and taking time to recover, during which time our Company Founder, Peter Ford, has stepped into the CEO role on a temporary basis.

Rob has now concluded that he will be unable to perform the demanding role of CEO, and instead must focus his energy on his health and his family. The Board has commenced a search process for a new permanent CEO.

Rob Wong remains a significant shareholder and is making himself available in an advisory capacity as needed, and will assist with the transition to a new CEO at the appropriate time.

We wish Rob all the very best with his ongoing treatment and recovery.

This announcement was authorised by CBL Chairman, Roger Hawke.

Control Bionics Limited Registered Office: Level 5, Suite 5.01, 697 Burke Road, Camberwell, Vic., 3124 T: +61 3 9897 3576 W: www.controlbionics.com

ABN: 45 115 465 462